F16.14 Hallucinogen abuse with hallucinogen-induced mood disorder

Name of the Condition

• Hallucinogen Abuse with Hallucinogen-Induced Mood Disorder
• Medical Term: ICD-10-CM F16.14

Summary

Hallucinogen abuse with hallucinogen-induced mood disorder involves the problematic use of hallucinogenic substances, accompanied by a mood disturbance directly attributed to their effects. This condition includes a pattern of use leading to clinically significant impairment, with mood symptoms (e.g., depression, mania) that are not better explained by another mental disorder and occur during or shortly after hallucinogen use.

Causes

Hallucinogen abuse typically stems from the recreational use of substances such as LSD, psilocybin mushrooms, mescaline, or PCP. The induced mood disorder arises from the direct pharmacological effects of these substances on brain chemistry, particularly serotonin and dopamine pathways, which can disrupt mood regulation.

Risk Factors

• Peer pressure or social influences encouraging drug use
• Curiosity or desire for altered states of consciousness
• Pre-existing mental health disorders (e.g., mood disorders)
• Genetic predisposition to substance use or mood disorders
• Easy access to hallucinogenic substances

Symptoms

• Visual or auditory hallucinations
• Altered perception of reality or time
• Euphoria, dysphoria, or mood swings
• Impaired coordination or speech
• Anxiety, paranoia, or panic reactions
• Persistent mood disturbances (e.g., depression, mania) linked to substance use

Diagnosis

Diagnosis is primarily clinical, based on a patient's history of substance use and reported symptoms. Mental health assessments may be used to evaluate the impact of use, and toxicology screens can confirm the presence of hallucinogens. The mood disorder must be directly attributable to hallucinogen use and not better explained by another condition.

Treatment Options

• Therapy: Cognitive behavioral therapy (CBT) to address thought patterns and mood regulation.
• Medication: Mood stabilizers or antidepressants (if needed) to manage induced mood symptoms.
• Support Groups: Participation in groups like Narcotics Anonymous for peer support.
• Education: Counseling on the risks of hallucinogen use and strategies for relapse prevention.

Prognosis and Follow-Up

Prognosis depends on the severity of abuse and mood symptoms, as well as adherence to treatment. Regular follow-up is essential to monitor mood stability, substance use, and overall functioning. Early intervention improves outcomes, but relapse risk remains if underlying factors are unaddressed.

Complications

• Worsening of mood symptoms (e.g., depression, mania)
• Increased risk of psychosis or persistent perceptual disturbances
• Social or occupational impairment due to substance use
• Potential for co-occurring substance use disorders or other mental health conditions

Lifestyle & Prevention

• Avoid hallucinogenic substances to prevent recurrence of mood symptoms.
• Engage in stress-reduction techniques (e.g., mindfulness, exercise) to support mental health.
• Build a strong support network of family, friends, or support groups.
• Seek professional help promptly if mood symptoms or cravings emerge.

When to Seek Professional Help

Seek immediate care if experiencing severe mood swings, suicidal thoughts, or persistent hallucinations. Contact a healthcare provider for ongoing substance use or mood disturbances that interfere with daily life.

Tips for Medical Coders

Document the presence of hallucinogen abuse and the specific mood disorder (e.g., depression, mania) induced by the substance. Ensure the mood symptoms are directly linked to hallucinogen use and not attributed to another condition. Include details on the pattern of use, duration, and clinical impact to support accurate coding.